Pain Relief Medication Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Pain Relief Medication Market covers analysis by Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Opioids, Others); Indication (Cancer Pain, Neuropathic Pain, Musculoskeletal Pain, Others); Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00011963
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Pain relievers are medicines that relieve headaches, sore muscles, arthritis, or other aches and pains. There are many different pain medicines, and each one has advantages and risks. Some types of pain respond better to certain medications than others. Medication is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy is an essential part of the medical field and relies on the science of pharmacology for continual advancement and pharmacy for appropriate management.

MARKET DYNAMICS



The pain relief medication market is driving due to the increasing expenditure capacity of the normal human beings, better inclusion in hospitals and various treatments. Moreover, hike in research funding, better drug development technology using AI and other advanced technologies, hike in clearance rate, government support boosts the growth of the market for pain relief medication.

MARKET SCOPE



The "Pain Relief Medication Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pain relief medication market with detailed market segmentation by drug class, indication and distribution channel. The pain relief medication market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pain relief medication market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The pain relief medication market is segmented on the basis of drug class, indication and distribution channel. Based on drug class, the market is segmented as nonsteroidal anti-inflammatory drugs, opioids and others. On the basis of indication, the market is categorized as cancer pain, neuropathic pain, musculoskeletal pain and others. On the basis of distribution channel, the market is categorized as hospital and retail pharmacies and online pharmacies.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pain relief medication market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pain relief medication market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pain relief medication market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pain relief medication market in these regions.


MARKET PLAYERS



The report covers key developments in the pain relief medication market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pain relief medication market are anticipated to have lucrative growth opportunities in the future with the rising demand for pain relief medication in the global market. Below mentioned is the list of few companies engaged in the pain relief medication market.

The report also includes the profiles of key players in pain relief medication market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   AbbVie Inc. (US)
  •   Allergan PLC (Ireland)
  •   Astellas Pharma Inc. (Japan)
  •   Bayer (Germany)
  •   Biogen Idec (US)
  •   Boehringer Ingelheim International GmbH (Germany)
  •   Bristol-Myers Squibb (US)
  •   Eli Lilly and Company (US)
  •   GlaxoSmithKline (UK)
  •   Mallinckrodt Pharmaceuticals (UK)
  •   Pfizer, Inc. (US)
  •   Purdue Pharma (US)
  •   Sanofi (France)


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Pain Relief Medication Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Drug Class
  • Nonsteroidal Anti-Inflammatory Drugs
  • Opioids
By Indication
  • Cancer Pain
  • Neuropathic Pain
  • Musculoskeletal Pain
By Distribution Channel
  • Hospital and Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc. (US)
  • Allergan PLC (Ireland)
  • Astellas Pharma Inc. (Japan)
  • Bayer (Germany)
  • Biogen Idec (US)
  • Boehringer Ingelheim International GmbH (Germany)
  • Bristol-Myers Squibb (US)
  • Eli Lilly and Company (US)
  • GlaxoSmithKline (UK)
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. AbbVie Inc. (US)
    2. Allergan PLC (Ireland)
    3. Astellas Pharma Inc. (Japan)
    4. Bayer (Germany)
    5. Biogen Idec (US)
    6. Boehringer Ingelheim International GmbH (Germany)
    7. Bristol-Myers Squibb (US)
    8. Eli Lilly and Company (US)
    9. GlaxoSmithKline (UK)
    10. Mallinckrodt Pharmaceuticals (UK)
    11. Pfizer, Inc. (US)
    12. Purdue Pharma (US)
    13. Sanofi (France)

    Buy Now